文献速递肿瘤 PET/CT放射性药物与辐射防护

多糖基止血剂的FDG PET/CT特征:慢性炎症改变可模仿转移性病灶

FDG PET/CT Features of Polysaccharide-Based Hemostatic Agent: Chronic Inflammatory Changes Can Mimic Metastatic Lesions.
PubMed 文献 · Clin Nucl Med · 2022-04-22

本研究纳入209例接受胸外科手术并术中应用多糖基止血剂的患者,其中42例术后行18F-FDG PET/CT,19例因怀疑转移而再次手术或活检。组织病理学显示11/19例标本中可见无定形嗜碱性止血剂材料,所有标本均见异物反应和/或异物肉芽肿伴慢性炎症;18F-FDG PET/CT显示这些病灶均FDG摄取增高。

要点

  • 多糖基止血剂可在术后长时间内于人体手术标本中显示为无定形嗜碱性材料。
  • 这些止血剂几乎总是引起慢性炎症改变,形成异物反应和/或异物肉芽肿。
  • 术后FDG PET/CT上止血剂所致慢性炎症可表现为FDG摄取增高,模仿转移性病灶。

核心结论

  • 尽管文献报道不一致,多糖基止血剂可在初次手术后很长时间仍于人体手术标本中显示为无定形嗜碱性材料。
  • 这些止血剂几乎总是引起慢性炎症改变。
  • 这些止血剂可能在术后FDG PET/CT扫描中模仿「假阳性」表现。

研究设计与样本

  • 本研究纳入209例连续接受胸外科手术的患者,所有患者术中手术床均应用局部多糖基止血剂。
  • 诊断为癌症的患者术后接受胸部CT随访,其中42例还接受了18F-FDG PET/CT检查,构成主要研究组。
  • 42例中19例因怀疑转移而再次手术或再次活检,以最新组织病理学发现为参考标准,回顾性重新评估既往FDG PET/CT图像。

主要发现

  • 19例再次手术或活检患者中,11例组织病理学标本中鉴定出无定形嗜碱性多糖基止血剂材料。
  • 所有组织病理学样本中均可见淋巴细胞、浆细胞和组织细胞,形成异物反应和/或异物肉芽肿,提示慢性炎症。
  • 18F-FDG PET/CT显示所有这些病灶FDG摄取增高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To prevent hemorrhagic complications, hemostatic agents (HAs) have been widely used in recent years. The use of HAs can lead to false-positive results on postoperative imaging. There exists only 1 study in the literature evaluating these applications during surgical procedures. Therefore, we aimed to evaluate the postoperative imaging features of polysaccharide-based HAs in thoracic surgery patients who have had 18F-FDG PET/CT scans. PATIENTS AND METHODS: Two hundred nine consecutive patients who underwent thoracic surgery were enrolled in this study. A topical polysaccharide-based HA was applied to the surgical bed for all of the patients. The patients diagnosed with cancer were followed up with subsequent thoracic CT scans, and 42 of these patients were also imaged with 18F-FDG PET/CT, which then comprised the main study group. Due to suspicion of metastasis, 19/42 patients were reoperated or rebiopsied. The latest histopathological findings were accepted as criterion standard, and previous FDG PET/CT images were retrospectively reevaluated. RESULTS: Polysaccharide-based HAs that appear as amorphous basophilic material were identified in histopathological samples of 11/19 patients. Lymphocytes, plasma cells, and histiocytes, which formed foreign body reaction and/or foreign body granuloma, indicating the presence of chronic inflammation, were seen in all of the samples. 18F-FDG PET/CT showed increased FDG uptake in all of these lesions. CONCLUSIONS: Despite the inconsistency of the literature, polysaccharide-based HAs can be demonstrated in human surgical specimens as amorphous basophilic materials even after a long time from the initial surgical procedure. These agents almost always cause chronic inflammatory changes. In addition, these agents may mimic "false-positive" findings on postoperative FDG PET/CT scans.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bozkurtlar E, Oksuzoglu K, Bostanci K, et al. FDG PET/CT Features of Polysaccharide-Based Hemostatic Agent: Chronic Inflammatory Changes Can Mimic Metastatic Lesions. Clin Nucl Med. 2022. PMID: 35452003. doi:10.1097/RLU.0000000000004216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。